HAEMONETICS CORP - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-11-07

Reporting Person: KROLL MARK W (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-14	Common Stock	G	1000	—	Disposed	27459	Direct
2018-08-16	Common Stock	G	200	—	Disposed	27259	Direct
2018-11-07	Common Stock	M	8196	$36.37	Acquired	35455	Direct
2018-11-07	Common Stock	S	10707	$114.00	Disposed	24748	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-07	Non-qualified Stock Option (Right to Buy)	$36.37	M	8196	Disposed	2019-07-27	Common Stock (8196)	Direct

F1: Shares transferred as a bona fide gift without any consideration.

F2: This number includes unvested restricted stock units previously reported.

F3: Transaction pursuant to an existing 10b5-1 trading plan.

F4: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.